Antipsychotic Use in Pregnancy and the Risk for Congenital Malformations
Author(s) -
Krista F. Huybrechts,
Sonia Hernández–Dı́az,
Elisabetta Patorno,
Rishi Desai,
Helen Mogun,
Sara Z. Dejene,
Jacqueline M. Cohen,
Alice Panchaud,
Lee S. Cohen,
Brian T. Bateman
Publication year - 2016
Publication title -
jama psychiatry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.531
H-Index - 365
eISSN - 2168-6238
pISSN - 2168-622X
DOI - 10.1001/jamapsychiatry.2016.1520
Subject(s) - medicine , pregnancy , atypical antipsychotic , antipsychotic , psychiatry , pediatrics , schizophrenia (object oriented programming) , genetics , biology
The frequency of antipsychotic (AP) use during pregnancy has approximately doubled during the last decade. However, little is known about their safety for the developing fetus, and concerns have been raised about a potential association with congenital malformations.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom